DelveInsight’s Cystinosis market report thoroughly explains the Cystinosis historical and forecasted epidemiology and the Cystinosis market trends in the 7MM.
Key Takeaways from the Cystinosis Market Report
- As per DelveInsight estimates, the total Cystinosis prevalent cases were 3008 in the 7MM in 2020, which is expected to increase during the study period (2018-30).
- In the United States, the highest cases were of Infantile Nephropathic Cystinosis, followed by Juveline Nephropathic Cystinosis and Non-Nephropathic Cystinosis in 2020.
- Leading players in the Cystinosis market include Eloxx Pharmaceuticals, Avrobio, and others.
- Key Cystinosis therapies in the pipeline include ELX-02, AVR-RD-04, and others.
- The Cystinosis market size was found to be USD 167 million in the 7MM in 2020.
Request for a sample to know more @ Cystinosis Market Outlook
Cystinosis Overview
Cystinosis is a disease caused by an abnormal accumulation of a specific amino acid known as cysteine. It is a rare but severe disease with long-term consequences that can affect many body parts. Cystinosis is classified into three types based on when symptoms first appear (known as onset): infantile (early-onset) cystinosis, late childhood or adolescent (late-onset) cystinosis, and adult cystinosis.
Cystinosis Epidemiology Segmentation
The Cystinosis report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
- Cystinosis Total Prevalent Cases
- Cystinosis Diagnosed Prevalent Cases
- Cystinosis Type-Specific Diagnosed Prevalent Cases
Cystinosis Treatment Landscape
There is currently no cure for Cystinosis, and treatment is limited to a few approved therapies that provide symptomatic relief. In the United States, three therapies are currently approved, one for ocular cystinosis and the other two for nephropathic cystinosis. The approved Cystinosis therapies include Procysbi (cysteamine bitartrate), Cystagon (cysteamine bitartrate), Cystaran (cysteamine hydrochloride), and Cystadrops (cysteamine hydrochloride).
Cystinosis Market Outlook
The Cystinosis market size was found to be USD 167 million in the 7MM in 2020.
The Cystinosis market will increase due to the introduction of new therapies such as ELX-02, AVR-RD-04, and others during the forecast period (2021-30).
Get a detailed analysis of the market @ Cystinosis Market Analysis
Cystinosis Pipeline Therapies and Key Companies
ELX-02: Eloxx Pharmaceuticals
AVR-RD-04 (CTNS-RD-04): Avrobio
Table of Contents
|
1. |
Key Insights |
|
2. |
Report Introduction |
|
3. |
Cystinosis Market Overview at a Glance |
|
4. |
Executive Summary of Cystinosis |
|
5. |
Key Events |
|
6. |
Disease Background and Overview |
|
7. |
Treatment and Management of Cystinosis |
|
8. |
Epidemiology and Patient Population |
|
9. |
Patient Journey |
|
10. |
Marketed Therapies |
|
11. |
Emerging Therapies |
|
12. |
Cystinosis: Seven Major Market Analysis |
|
13. |
KOL Views |
|
14. |
Market Drivers |
|
15. |
Market Barriers |
|
16. |
SWOT Analysis |
|
17. |
Unmet Needs |
|
18. |
Market Access and Reimbursement |
|
19. |
Appendix |
|
20. |
DelveInsight Capabilities |
|
21. |
Disclaimer |
|
22. |
About DelveInsight |
Get in touch with our business executive for Healthcare Due Diligence Services
Related Reports
Nephropathic Cystinosis Market
DelveInsight’s “Nephropathic Cystinosis – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Nephropathic Cystinosis , historical and forecasted epidemiology as well as the Nephropathic Cystinosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/